UBA6抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using P09297(UBA6 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P09297(UBA6 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The UBA6 antibody is a crucial tool in studying the ubiquitin-proteasome system (UPS), a major pathway for targeted protein degradation in eukaryotic cells. UBA6. a ubiquitin-activating enzyme (E1), initiates the ubiquitination cascade by activating and transferring ubiquitin or ubiquitin-like (UBL) proteins, such as FAT10. to downstream E2 conjugating enzymes. Unlike its paralog UBA1. UBA6 exhibits unique substrate specificity, preferentially activating FAT10. which plays roles in immune regulation, apoptosis, and cell cycle control. UBA6’s involvement in these processes links it to diseases like cancer, neurodegenerative disorders, and autoimmune conditions.

Antibodies targeting UBA6 enable researchers to investigate its expression, localization, and interactions via techniques like Western blotting, immunofluorescence, and immunoprecipitation. These studies help elucidate UBA6’s regulatory mechanisms in protein homeostasis, inflammation, and stress responses. Dysregulation of UBA6 has been implicated in tumor progression and neuropathologies, making it a potential therapeutic target. The development of specific UBA6 antibodies has advanced understanding of its dual roles in canonical ubiquitination and non-canonical FAT10 pathways, highlighting its functional complexity. Such tools remain vital for exploring UPS-related diseases and developing targeted interventions.